BLOOD, LYMPH AND RELATED CONDITIONS:@0.084848:0.038601:0.564720:0.038601:0.564720:0.019343:0.084848:0.019343:0.013500:0.010866:0.020438:0.020438:0.017498:0.006515:0.006515:0.008735:0.013923:0.021613:0.013923:0.016063:0.006515:0.017404:0.017404:0.017498:0.006515:0.014276:0.012606:0.010866:0.015466:0.010019:0.012606:0.017498:0.006515:0.019121:0.020438:0.017404:0.017498:0.005315:0.010019:0.005315:0.020438:0.017404:0.011712
86:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
of 1% per year. Therefore, a “second-hit” is :@0.084848:0.096166:0.481090:0.096166:0.481090:0.080410:0.084848:0.080410:0.012604:0.006042:0.004984:0.010660:0.014913:0.004984:0.013123:0.012508:0.005792:0.004984:0.010314:0.012508:0.013143:0.004381:0.005330:0.004984:0.008197:0.011738:0.012508:0.005703:0.012508:0.006042:0.012604:0.005707:0.012508:0.005330:0.004984:0.013143:0.004984:0.009660:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.006388:0.011738:0.003848:0.006523:0.009313:0.004972:0.003848:0.007466:0.005330
required to progress to MM.:@0.084848:0.112517:0.340940:0.112517:0.340940:0.096761:0.084848:0.096761:0.005713:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.013181:0.005330:0.006523:0.012604:0.005330:0.013123:0.005702:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.005330:0.006523:0.012604:0.005330:0.017684:0.017684:0.005330
11:@0.340928:0.106903:0.353358:0.106903:0.353358:0.097718:0.340928:0.097718:0.006215:0.006215
The “second-hit” is due to additional ge-:@0.103030:0.128879:0.475773:0.128879:0.475773:0.113123:0.103030:0.113123:0.008005:0.011545:0.012315:0.005782:0.009467:0.007274:0.012315:0.012257:0.012411:0.011545:0.012989:0.006196:0.011545:0.003656:0.006331:0.009121:0.005782:0.003656:0.007274:0.005782:0.012989:0.011507:0.012315:0.005780:0.006331:0.012411:0.005782:0.012950:0.012989:0.012989:0.003656:0.006331:0.003656:0.012411:0.011545:0.012950:0.003656:0.005782:0.012758:0.012315:0.006388
netic changes (e.g., Ras mutations, p53 :@0.084846:0.145231:0.481090:0.145231:0.481090:0.129475:0.084846:0.129475:0.011545:0.012315:0.006331:0.003656:0.012257:0.011199:0.012257:0.011545:0.012950:0.011545:0.012758:0.012315:0.007274:0.011199:0.006908:0.012315:0.005138:0.012758:0.005138:0.005138:0.011199:0.011488:0.012950:0.007274:0.011199:0.017857:0.011507:0.006331:0.012950:0.006331:0.003656:0.012411:0.011545:0.007274:0.005138:0.011199:0.012931:0.010468:0.010664:0.005330
mutations), as well as permissive changes :@0.084846:0.161582:0.481063:0.161582:0.481063:0.145826:0.084846:0.145826:0.017857:0.011507:0.006331:0.012950:0.006331:0.003656:0.012411:0.011545:0.007274:0.006908:0.005138:0.007678:0.012950:0.007274:0.007678:0.015798:0.012315:0.003656:0.003656:0.007678:0.012950:0.007274:0.007678:0.012931:0.012315:0.006131:0.017857:0.003656:0.007274:0.007274:0.003656:0.010468:0.012315:0.007678:0.012257:0.011545:0.012950:0.011545:0.012758:0.012315:0.007470:0.005330
in the bone-marrow environment and eva-:@0.084846:0.177933:0.475810:0.177933:0.475810:0.162177:0.084846:0.162177:0.003656:0.011545:0.004984:0.006331:0.011545:0.012315:0.004984:0.012931:0.012411:0.011545:0.012315:0.006196:0.017857:0.012950:0.005600:0.005521:0.012411:0.015798:0.004984:0.012315:0.011545:0.010468:0.003656:0.005521:0.012411:0.011545:0.017857:0.012315:0.011545:0.006331:0.004984:0.012950:0.011545:0.012989:0.004984:0.012315:0.010468:0.012950:0.006388
sion of immune surveillance.  The net result :@0.084846:0.194284:0.481114:0.194307:0.481114:0.178551:0.084846:0.178528:0.007274:0.003656:0.012411:0.011545:0.004945:0.012411:0.005850:0.004945:0.003656:0.017857:0.017857:0.011507:0.011545:0.012315:0.004945:0.007274:0.011507:0.005600:0.010468:0.012315:0.003656:0.003656:0.003656:0.012950:0.011545:0.012257:0.012315:0.005330:0.012002:0.004945:0.008005:0.011545:0.012315:0.004945:0.011545:0.012315:0.006331:0.004945:0.005521:0.012315:0.007274:0.011507:0.003656:0.006519:0.719051
10:@0.339889:0.188688:0.352207:0.188688:0.352207:0.179502:0.339889:0.179502:0.006103:0.006215
of these changes is an increase in prolifera-:@0.084841:0.210658:0.475728:0.210658:0.475728:0.194902:0.084841:0.194902:0.012411:0.005850:0.004637:0.006331:0.011545:0.012315:0.007274:0.012315:0.004637:0.012257:0.011545:0.012950:0.011545:0.012758:0.012315:0.007274:0.004637:0.003656:0.007274:0.004637:0.012950:0.011545:0.004637:0.003656:0.011545:0.012257:0.005521:0.012315:0.012950:0.007274:0.012315:0.004637:0.003656:0.011545:0.004637:0.012931:0.005521:0.012411:0.003656:0.003656:0.005850:0.012315:0.005600:0.012950:0.006388
tion and survival of the malignant clone.:@0.084841:0.227009:0.451890:0.227009:0.451890:0.211253:0.084841:0.211253:0.006331:0.003656:0.012411:0.011545:0.005138:0.012950:0.011545:0.012989:0.005138:0.007274:0.011507:0.005600:0.010468:0.003656:0.010468:0.012950:0.003656:0.005138:0.012411:0.005850:0.005138:0.006331:0.011545:0.012315:0.005138:0.017857:0.012950:0.003656:0.003656:0.012758:0.011545:0.012950:0.011545:0.006331:0.005138:0.012257:0.003656:0.012411:0.011545:0.012315:0.005330
DIAGNOSTIC ISSUES:@0.084848:0.260381:0.306393:0.260381:0.306393:0.240784:0.084848:0.240784:0.016463:0.006585:0.017404:0.019756:0.017404:0.019756:0.012230:0.009878:0.006585:0.018344:0.006585:0.006585:0.012230:0.012230:0.015052:0.012230:0.012230
DIAGNOSTIC CRITERIA:@0.084848:0.279354:0.311481:0.279354:0.311481:0.261539:0.084848:0.261539:0.014966:0.005987:0.015822:0.017960:0.015822:0.017960:0.011118:0.008980:0.005987:0.016677:0.005987:0.016677:0.012401:0.005987:0.008980:0.011118:0.012401:0.005987:0.015822
The diagnosis of MM has been based on :@0.084848:0.296857:0.481103:0.296857:0.481103:0.281101:0.084848:0.281101:0.008197:0.011738:0.012508:0.007453:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.007466:0.012604:0.006042:0.007456:0.017684:0.017684:0.007466:0.011738:0.013143:0.007466:0.007466:0.013123:0.012508:0.012508:0.011738:0.007466:0.013123:0.013143:0.007466:0.012508:0.013181:0.007466:0.012604:0.011738:0.005330
demonstrating a clonal plasma-cell popu-:@0.084848:0.313209:0.475754:0.313209:0.475754:0.297453:0.084848:0.297453:0.013181:0.012508:0.018049:0.012604:0.011738:0.007466:0.006523:0.005792:0.013143:0.006523:0.003848:0.011738:0.012950:0.004814:0.013143:0.004830:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.004830:0.013123:0.003848:0.013143:0.007466:0.018061:0.013143:0.006388:0.012450:0.012508:0.003848:0.003848:0.004830:0.013123:0.012604:0.013123:0.011699:0.006388
lation, usually  with the production of an :@0.084848:0.329560:0.481121:0.329560:0.481121:0.313804:0.084848:0.313804:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.009333:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.005330:0.004016:0.015990:0.003848:0.006523:0.011738:0.009333:0.006523:0.011738:0.012508:0.009333:0.013123:0.005715:0.012604:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.009333:0.012604:0.006042:0.009333:0.013143:0.011738:0.005330
M-protein, along with end-organ features. :@0.084848:0.345911:0.481080:0.345911:0.481080:0.330155:0.084848:0.330155:0.017684:0.006388:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.005330:0.005523:0.013143:0.003848:0.012604:0.011738:0.012950:0.005523:0.015990:0.003848:0.006523:0.011738:0.005523:0.012508:0.011738:0.013181:0.006388:0.012604:0.005792:0.012950:0.013143:0.011738:0.005523:0.006042:0.012508:0.013143:0.006523:0.011699:0.005707:0.012508:0.007466:0.005330:0.005330
The  2014 International Myeloma Working :@0.084848:0.362262:0.481113:0.362262:0.481113:0.346506:0.084848:0.346506:0.008197:0.011738:0.012508:0.005330:0.003564:0.010660:0.010660:0.010672:0.010660:0.008909:0.004349:0.011738:0.006523:0.012508:0.006186:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.008909:0.017684:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.008909:0.017588:0.012604:0.005792:0.009660:0.003848:0.011738:0.012950:0.005330
Group (IMWG) updated these criteria (see :@0.084848:0.378614:0.481105:0.378614:0.481105:0.362858:0.084848:0.362858:0.016779:0.005713:0.012604:0.011699:0.013123:0.004387:0.007100:0.004349:0.017684:0.018473:0.016779:0.007100:0.004387:0.011699:0.013123:0.013181:0.013143:0.006523:0.012508:0.013181:0.004387:0.006523:0.011738:0.012508:0.007466:0.012508:0.004387:0.012450:0.005792:0.003848:0.006523:0.012508:0.005792:0.003848:0.013143:0.004387:0.007100:0.007466:0.012508:0.012508:0.005330
Table 1),  recognising that a subset of pa-:@0.084848:0.394965:0.475766:0.394998:0.475766:0.379242:0.084848:0.379209:0.007197:0.013143:0.013123:0.003848:0.012508:0.005234:0.010660:0.007100:0.005330:0.012439:0.005234:0.005711:0.012508:0.012450:0.012604:0.012950:0.011738:0.003848:0.007466:0.003848:0.011738:0.012950:0.005222:0.006523:0.011738:0.013143:0.006523:0.005222:0.013143:0.005234:0.007466:0.011699:0.013123:0.007466:0.012508:0.006523:0.005234:0.012604:0.006042:0.005222:0.013123:0.013143:0.433542
12:@0.162996:0.389379:0.175426:0.389379:0.175426:0.380194:0.162996:0.380194:0.006215:0.006215
tients  previously  classified  as  SMM  have :@0.084856:0.411350:0.481090:0.411350:0.481090:0.395594:0.084856:0.395594:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.005388:0.013123:0.005715:0.012508:0.010660:0.003848:0.012604:0.011699:0.007466:0.003848:0.010314:0.005330:0.005397:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.013181:0.005330:0.005401:0.013143:0.007466:0.005330:0.005396:0.009583:0.017684:0.017684:0.005330:0.005390:0.011738:0.013143:0.010660:0.012508:0.005330
near inevitable progression to end-organ :@0.084856:0.427701:0.481107:0.427701:0.481107:0.411945:0.084856:0.411945:0.011738:0.012508:0.013143:0.005792:0.007764:0.003848:0.011738:0.012508:0.010660:0.003848:0.006523:0.013143:0.013123:0.003848:0.012519:0.007774:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.007774:0.006523:0.012604:0.007774:0.012508:0.011738:0.013181:0.006388:0.012604:0.005792:0.012950:0.013143:0.011738:0.005330
damage and for this reason have been in-:@0.084856:0.444052:0.475791:0.444052:0.475791:0.428296:0.084856:0.428296:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.004686:0.013143:0.011738:0.013181:0.004695:0.006042:0.012604:0.005792:0.004682:0.006523:0.011738:0.003848:0.007466:0.004695:0.005711:0.012508:0.013143:0.007466:0.012604:0.011738:0.004684:0.011738:0.013143:0.010660:0.012508:0.004695:0.013123:0.012508:0.012508:0.011738:0.004682:0.003848:0.011738:0.006388
cluded as MM (patients with >60% plasma :@0.084856:0.460403:0.481057:0.460403:0.481057:0.444647:0.084856:0.444647:0.012450:0.003848:0.011699:0.013181:0.012508:0.013181:0.005215:0.013143:0.007466:0.005215:0.017684:0.017684:0.005215:0.007100:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005215:0.015990:0.003848:0.006523:0.011738:0.005215:0.011661:0.010660:0.010660:0.014913:0.005215:0.013123:0.003848:0.013143:0.007466:0.018049:0.013143:0.005330
cells in the  bone  marrow;  involved/unin-:@0.084856:0.476755:0.475770:0.476755:0.475770:0.460999:0.084856:0.460999:0.012450:0.012508:0.003848:0.003848:0.007466:0.009005:0.003848:0.011738:0.009005:0.006523:0.011738:0.012508:0.005330:0.003658:0.013123:0.012604:0.011738:0.012508:0.005330:0.003660:0.018049:0.013143:0.005792:0.005709:0.012604:0.015990:0.005330:0.005330:0.003660:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.013181:0.008409:0.011699:0.011738:0.003848:0.011738:0.006388
volved FLC ratio of >10).:@0.084856:0.493106:0.309473:0.493106:0.309473:0.477350:0.084856:0.477350:0.010660:0.012604:0.003848:0.010660:0.012508:0.013181:0.005330:0.009333:0.008890:0.015644:0.005330:0.005792:0.013143:0.006523:0.003848:0.012604:0.005330:0.012604:0.006042:0.005330:0.011661:0.010660:0.010660:0.007100:0.005330
CLINICAL FEATURES:@0.084848:0.526176:0.281121:0.526176:0.281121:0.508361:0.084848:0.508361:0.016677:0.009407:0.005987:0.015822:0.005987:0.016677:0.015822:0.009407:0.005987:0.010263:0.011118:0.015822:0.008980:0.013683:0.012401:0.011118:0.011118
Patients with MM commonly present with :@0.084848:0.543680:0.481088:0.543680:0.481088:0.527924:0.084848:0.527924:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007393:0.015990:0.003848:0.006523:0.011738:0.007395:0.017684:0.017684:0.007395:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.003848:0.010314:0.007391:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.007391:0.015990:0.003848:0.006523:0.011738:0.005330
symptoms  related to end-organ features :@0.084848:0.560031:0.481069:0.560031:0.481069:0.544275:0.084848:0.544275:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330:0.003456:0.005711:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.008775:0.006523:0.012604:0.008775:0.012508:0.011738:0.013181:0.006388:0.012604:0.005792:0.012950:0.013143:0.011738:0.008775:0.006042:0.012508:0.013143:0.006523:0.011699:0.005707:0.012508:0.007466:0.005330
(often  recalled by the  acronym  CRAB): :@0.084848:0.576382:0.481088:0.576382:0.481088:0.560626:0.084848:0.560626:0.007100:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.005451:0.005711:0.012508:0.012450:0.013143:0.003848:0.003848:0.012508:0.013181:0.010795:0.013123:0.010314:0.010795:0.006523:0.011738:0.012508:0.005330:0.005453:0.013143:0.012450:0.005715:0.012604:0.011738:0.010314:0.018049:0.005330:0.005455:0.015644:0.011680:0.014239:0.011045:0.007100:0.005330:0.005330
increased plasma  alcium,  enal dysfunc-:@0.084848:0.592734:0.475777:0.592734:0.475777:0.576978:0.084848:0.576978:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.013181:0.005561:0.013123:0.003848:0.013143:0.007466:0.018061:0.013143:0.005330:0.012546:0.013143:0.003848:0.012450:0.003848:0.011699:0.018049:0.005330:0.005330:0.006379:0.012508:0.011738:0.013143:0.003848:0.005561:0.013181:0.010314:0.007466:0.006042:0.011699:0.011738:0.012450:0.006388
c:@0.257308:0.592734:0.269624:0.592734:0.269624:0.576700:0.257308:0.576700:0.012315
r:@0.343543:0.592734:0.349701:0.592734:0.349701:0.576700:0.343543:0.576700:0.006158
tion,  naemia and  one pain. An uncom-:@0.084848:0.609085:0.475758:0.609085:0.475758:0.593329:0.084848:0.593329:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.012700:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005349:0.013143:0.011738:0.013181:0.005330:0.012719:0.012604:0.011738:0.012508:0.005334:0.013123:0.013143:0.003848:0.011738:0.005330:0.005340:0.014239:0.011738:0.005336:0.011699:0.011738:0.012450:0.012604:0.018049:0.006388
a:@0.130222:0.609085:0.142922:0.609085:0.142922:0.593051:0.130222:0.593051:0.012700
b:@0.264111:0.609085:0.276811:0.609085:0.276811:0.593051:0.264111:0.593051:0.012700
mon  presentation,  but  a  medical emer-:@0.084848:0.625436:0.475773:0.625436:0.475773:0.609680:0.084848:0.609680:0.018049:0.012604:0.011738:0.005330:0.004464:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.004466:0.013123:0.011699:0.006523:0.005330:0.004470:0.013143:0.005330:0.004472:0.018049:0.012508:0.013181:0.003848:0.012450:0.013143:0.003848:0.009814:0.012508:0.018049:0.012508:0.005792:0.006388
gency, is that of spinal cord compression.:@0.084848:0.641787:0.469960:0.641787:0.469960:0.626031:0.084848:0.626031:0.012950:0.012508:0.011738:0.012450:0.010314:0.005330:0.005330:0.003848:0.007466:0.005330:0.006523:0.011738:0.013143:0.006523:0.005330:0.012604:0.006042:0.005330:0.007466:0.013123:0.003848:0.011738:0.013143:0.003848:0.005330:0.012450:0.012604:0.005657:0.013181:0.005330:0.012450:0.012604:0.018049:0.013123:0.005709:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330
Anaemia in MM is typically  normocytic :@0.084848:0.658139:0.481074:0.658139:0.481074:0.642383:0.084848:0.642383:0.014239:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.011526:0.003848:0.011738:0.011526:0.017684:0.017684:0.011526:0.003848:0.007466:0.011526:0.006523:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.006217:0.011738:0.012604:0.006315:0.018049:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.005330
and normochromic and is present in 73% :@0.084848:0.674490:0.481065:0.674490:0.481065:0.658734:0.084848:0.658734:0.013143:0.011738:0.013181:0.007312:0.011738:0.012604:0.006323:0.018049:0.012604:0.012450:0.011738:0.005705:0.012604:0.018049:0.003848:0.012450:0.007312:0.013143:0.011738:0.013181:0.007312:0.003848:0.007466:0.007326:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.007312:0.003848:0.011738:0.007312:0.010660:0.010660:0.014913:0.005330
of  cases at diagnosis.  Anaemia  can be :@0.084848:0.690841:0.481103:0.690891:0.481103:0.675135:0.084848:0.675085:0.012604:0.006042:0.005330:0.003356:0.012450:0.013143:0.007466:0.012508:0.007466:0.008698:0.013143:0.006523:0.008698:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.006213:0.008698:0.014239:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.003358:0.012450:0.013143:0.011738:0.008698:0.013123:0.012508:-0.003243
5:@0.293843:0.685272:0.300058:0.685272:0.300058:0.676087:0.293843:0.676087:0.006215
related to bone-marrow infiltration, kidney :@0.084853:0.707243:0.481101:0.707243:0.481101:0.691487:0.084853:0.691487:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.005294:0.006523:0.012604:0.005290:0.013123:0.012604:0.011738:0.012508:0.006388:0.018049:0.013143:0.005792:0.005711:0.012604:0.015990:0.005292:0.003848:0.011738:0.004686:0.004686:0.003848:0.006523:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005286:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.005330
damage,  cytokines affecting  erythropoi-:@0.084853:0.723594:0.475784:0.723594:0.475784:0.707838:0.084853:0.707838:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.005330:0.005330:0.004355:0.012450:0.010314:0.006523:0.012604:0.009660:0.003848:0.011738:0.012508:0.007466:0.009698:0.013143:0.006100:0.006042:0.012508:0.012450:0.006523:0.003848:0.011738:0.012950:0.005330:0.004356:0.012508:0.005792:0.010314:0.006523:0.011738:0.005703:0.012604:0.013123:0.012604:0.003848:0.006388
etin release and is dilutional (in the case :@0.084853:0.739945:0.481070:0.739945:0.481070:0.724189:0.084853:0.724189:0.012508:0.006523:0.003848:0.011738:0.007986:0.005711:0.012508:0.003848:0.012508:0.013143:0.007466:0.012508:0.007986:0.013143:0.011738:0.013181:0.007986:0.003848:0.007466:0.007986:0.013181:0.003848:0.003848:0.011699:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.007986:0.007100:0.003848:0.011738:0.007986:0.006523:0.011738:0.012508:0.007986:0.012450:0.013143:0.007466:0.012508:0.005330
of a large M-protein). An unexplained nor-:@0.084853:0.756296:0.475763:0.756296:0.475763:0.740540:0.084853:0.740540:0.012604:0.006042:0.005065:0.013143:0.005070:0.003848:0.013143:0.005813:0.012950:0.012508:0.005063:0.017684:0.006388:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.007100:0.005330:0.005061:0.014239:0.011738:0.005063:0.011699:0.011738:0.012508:0.009236:0.013123:0.003848:0.013143:0.003848:0.011738:0.012508:0.013181:0.005080:0.011351:0.012213:0.005396:0.006388
mocytic normochromic anaemia in a pa-:@0.084853:0.772648:0.475755:0.772648:0.475755:0.756892:0.084853:0.756892:0.017665:0.012219:0.012065:0.009929:0.006138:0.003464:0.012065:0.008293:0.011353:0.012219:0.005940:0.017665:0.012219:0.012065:0.011353:0.005328:0.012219:0.017665:0.003464:0.012065:0.008293:0.012758:0.011353:0.012758:0.012123:0.017665:0.003464:0.012758:0.008293:0.003464:0.011353:0.008293:0.012758:0.008293:0.012738:0.012758:0.006388
tient (especially with other “red flags” such :@0.084853:0.788999:0.481093:0.788999:0.481093:0.773243:0.084853:0.773243:0.006138:0.003464:0.012123:0.011353:0.006138:0.006664:0.006716:0.012123:0.007081:0.012738:0.012123:0.012065:0.003464:0.012758:0.003464:0.003464:0.009929:0.006664:0.015606:0.003464:0.006138:0.011353:0.006662:0.012219:0.006138:0.011353:0.012123:0.005407:0.006662:0.009275:0.005326:0.012123:0.012796:0.006662:0.004474:0.004474:0.012758:0.012565:0.007081:0.008928:0.006662:0.007081:0.011315:0.012065:0.011734:0.005330
as bone pain, weight loss, fatigue and other :@0.084853:0.805350:0.481116:0.805350:0.481116:0.789594:0.084853:0.789594:0.012758:0.007081:0.004686:0.012738:0.012219:0.011353:0.012123:0.004695:0.012738:0.012758:0.003464:0.011353:0.004945:0.004686:0.015606:0.012123:0.003464:0.012565:0.011353:0.006138:0.004695:0.003464:0.012219:0.007081:0.007081:0.004945:0.004686:0.005657:0.012758:0.006138:0.003464:0.012565:0.011315:0.012123:0.004686:0.012758:0.011353:0.012796:0.004686:0.012219:0.006138:0.011353:0.012123:0.005786:0.005330
cytopaenias) warrants further investigation :@0.084853:0.821701:0.481091:0.821701:0.481091:0.805945:0.084853:0.805945:0.012065:0.009929:0.006138:0.012219:0.012738:0.012758:0.012123:0.011353:0.003464:0.012758:0.007081:0.006716:0.008293:0.015606:0.012758:0.005407:0.005407:0.012758:0.011353:0.006138:0.007081:0.008293:0.005657:0.011315:0.005407:0.006138:0.011353:0.012123:0.005407:0.008293:0.003464:0.011353:0.010275:0.012123:0.007081:0.006138:0.003464:0.012565:0.012758:0.006138:0.003464:0.012219:0.011736:0.005330
with a bone-marrow examination (BME) :@0.084853:0.838053:0.481112:0.838053:0.481112:0.822297:0.084853:0.822297:0.015606:0.003464:0.006138:0.011353:0.013585:0.012758:0.013585:0.012738:0.012219:0.011353:0.012123:0.006004:0.017665:0.012758:0.005407:0.005328:0.012219:0.015606:0.013585:0.012123:0.008852:0.012758:0.017665:0.003464:0.011353:0.012758:0.006138:0.003464:0.012219:0.011353:0.013585:0.006716:0.010660:0.017299:0.009929:0.007102:0.005330
and serum electrophoresis (SPEP).:@0.084853:0.854404:0.384933:0.854404:0.384933:0.838648:0.084853:0.838648:0.012758:0.011353:0.012796:0.004945:0.007081:0.012123:0.005407:0.011315:0.017665:0.004945:0.012123:0.003464:0.012123:0.012065:0.006138:0.005328:0.012219:0.012738:0.011353:0.012219:0.005326:0.012123:0.007081:0.003464:0.007081:0.004945:0.006716:0.009198:0.011007:0.009929:0.011007:0.006716:0.005330
Bone pain is the presenting feature at di-:@0.103038:0.870755:0.475774:0.870755:0.475774:0.854999:0.103038:0.854999:0.011045:0.012604:0.011738:0.012508:0.004503:0.013123:0.013143:0.003848:0.011738:0.004560:0.003848:0.007466:0.004503:0.006523:0.011738:0.012508:0.004503:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.003848:0.011738:0.012950:0.004503:0.006042:0.012508:0.013143:0.006523:0.011699:0.005707:0.012508:0.004503:0.013143:0.006523:0.004503:0.013181:0.003848:0.006388
 :@0.197287:0.870755:0.202675:0.870755:0.202675:0.854721:0.197287:0.854721:0.005388
agnosis in 60% of cases  and is typically in :@0.084873:0.887106:0.481079:0.887173:0.481079:0.871417:0.084873:0.871350:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.006196:0.003848:0.011738:0.006196:0.010660:0.010660:0.014913:0.006196:0.012604:0.006042:0.006196:0.012450:0.013143:0.007466:0.012508:0.007466:0.006203:0.006196:0.013143:0.011738:0.013181:0.006196:0.003848:0.007466:0.006196:0.006523:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.006213:0.003848:0.011738:-0.288720
5:@0.302356:0.881554:0.308571:0.881554:0.308571:0.872369:0.302356:0.872369:0.006215
the back or chest. Imaging may show lytic :@0.084841:0.903525:0.481085:0.903525:0.481085:0.887769:0.084841:0.887769:0.006523:0.011738:0.012508:0.004857:0.013123:0.013143:0.012450:0.009660:0.004868:0.012604:0.005792:0.004855:0.012450:0.011738:0.012508:0.007466:0.006523:0.005330:0.004859:0.004349:0.018049:0.013143:0.012950:0.003848:0.011738:0.012950:0.004868:0.018049:0.013143:0.010314:0.004868:0.007466:0.011738:0.012604:0.015990:0.004868:0.003848:0.010314:0.006523:0.003848:0.012450:0.005330
lesions, pathological fractures, vertebral :@0.084841:0.919876:0.481089:0.919876:0.481089:0.904120:0.084841:0.904120:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.007466:0.005330:0.011911:0.013123:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.011911:0.006042:0.005792:0.013143:0.012450:0.006523:0.011699:0.005703:0.012508:0.007466:0.005330:0.011911:0.010660:0.012508:0.005792:0.006523:0.012508:0.013123:0.005792:0.013143:0.003848:0.005330
compression fractures, and osteopaenia. :@0.084841:0.936227:0.481093:0.936227:0.481093:0.920471:0.084841:0.920471:0.012450:0.012604:0.018049:0.013123:0.005711:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.008032:0.006042:0.005792:0.013143:0.012450:0.006523:0.011699:0.005711:0.012508:0.007466:0.005330:0.008028:0.013143:0.011738:0.013181:0.008032:0.012604:0.007466:0.006523:0.012508:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.005330
Lesions are more sensitively diagnosed by :@0.524242:0.096149:0.920487:0.096149:0.920487:0.080393:0.524242:0.080393:0.008890:0.012508:0.007466:0.003848:0.012604:0.011738:0.007466:0.006273:0.013143:0.005715:0.012508:0.006273:0.018049:0.012604:0.005707:0.012508:0.006273:0.007466:0.012508:0.011738:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.003848:0.010314:0.006286:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.006273:0.013123:0.010314:0.005330
CT, PET CT or MRI than x-ray. Lytic lesions :@0.524242:0.112619:0.920454:0.112619:0.920454:0.096863:0.524242:0.096863:0.015644:0.006229:0.005330:0.007928:0.011392:0.010314:0.008197:0.007928:0.015644:0.008197:0.007928:0.012604:0.005792:0.007928:0.017684:0.011680:0.004349:0.007928:0.006523:0.011738:0.013143:0.011738:0.007928:0.009236:0.006388:0.005792:0.013143:0.010314:0.005330:0.007928:0.008445:0.010314:0.006523:0.003848:0.012450:0.007928:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.007466:0.005330
develop as a result of excessive osteoclas-:@0.524242:0.129089:0.915122:0.129089:0.915122:0.113333:0.524242:0.113333:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.004772:0.013143:0.007466:0.004772:0.013143:0.004772:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.004772:0.012604:0.006042:0.004772:0.012508:0.009236:0.012450:0.012508:0.007466:0.007466:0.003848:0.010672:0.012508:0.004772:0.012604:0.007466:0.006523:0.012508:0.012604:0.012450:0.003848:0.013143:0.007466:0.006388
tic activity driven by cytokines produced :@0.524242:0.145559:0.920487:0.145559:0.920487:0.129804:0.524242:0.129804:0.006523:0.003848:0.012450:0.007607:0.013143:0.012450:0.006523:0.003848:0.010660:0.003848:0.006523:0.010314:0.007610:0.013181:0.005792:0.003848:0.010660:0.012508:0.011738:0.007603:0.013123:0.010314:0.007620:0.012450:0.010314:0.006523:0.012604:0.009660:0.003848:0.011738:0.012508:0.007466:0.007608:0.013123:0.005715:0.012604:0.013181:0.011699:0.012450:0.012508:0.013181:0.005330
by MM cells.:@0.524242:0.162030:0.639157:0.162030:0.639157:0.146274:0.524242:0.146274:0.013123:0.010314:0.005330:0.017684:0.017684:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330
Renal dysfunction occurs in 48% of pa-:@0.542426:0.178500:0.915132:0.178500:0.915132:0.162744:0.542426:0.162744:0.011680:0.012508:0.011738:0.013143:0.003848:0.007755:0.013181:0.010314:0.007466:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.007832:0.012604:0.012450:0.012450:0.011699:0.005792:0.007466:0.007755:0.003848:0.011738:0.007755:0.010660:0.010660:0.014913:0.007755:0.012604:0.006042:0.007755:0.013123:0.013143:0.006388
 :@0.710701:0.178500:0.716089:0.178500:0.716089:0.162466:0.710701:0.162466:0.005388
tients at diagnosis, is often  multifactorial :@0.524242:0.194970:0.920475:0.194998:0.920475:0.179242:0.524242:0.179214:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009333:0.013143:0.006523:0.009333:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.011651:0.003848:0.007466:0.009333:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.003987:0.018049:0.011699:0.003848:0.006523:0.003848:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.003848:0.013143:0.003848:0.278683
5 :@0.702748:0.189379:0.712071:0.189379:0.712071:0.180194:0.702748:0.180194:0.006215:0.003107
in aetiology and is often reversible. Com-:@0.524251:0.211469:0.915185:0.211469:0.915185:0.195713:0.524251:0.195713:0.003848:0.011738:0.007043:0.013143:0.012508:0.006523:0.003848:0.012604:0.003848:0.012604:0.012950:0.010314:0.007033:0.013143:0.011738:0.013181:0.007043:0.003848:0.007466:0.007043:0.012604:0.006042:0.006523:0.012508:0.011738:0.007023:0.005711:0.012508:0.010660:0.012508:0.005792:0.007466:0.003848:0.013123:0.003848:0.012508:0.005330:0.007043:0.015644:0.012604:0.018049:0.006388
mon  causes for  renal dysfunction  in my-:@0.524251:0.227939:0.915164:0.227939:0.915164:0.212183:0.524251:0.212183:0.018049:0.012604:0.011738:0.005330:0.003741:0.012450:0.013143:0.011699:0.007466:0.012508:0.007466:0.009082:0.006042:0.012604:0.005792:0.005330:0.003743:0.005713:0.012508:0.011738:0.013143:0.003848:0.009082:0.013181:0.010314:0.007466:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.003741:0.003848:0.011738:0.009082:0.018049:0.010314:0.006388
eloma are light-chain cast nephropathy :@0.524251:0.244409:0.920487:0.244409:0.920487:0.228653:0.524251:0.228653:0.012508:0.003848:0.012604:0.018049:0.013143:0.009833:0.013143:0.005715:0.012508:0.009833:0.003848:0.003848:0.012950:0.011738:0.006523:0.006388:0.012450:0.011738:0.013143:0.003848:0.011738:0.009833:0.012450:0.013143:0.007466:0.006523:0.009833:0.011738:0.012508:0.013123:0.011738:0.005711:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314:0.005330
(deposition of light chains in the tubules, :@0.524251:0.260880:0.920490:0.260880:0.920490:0.245124:0.524251:0.245124:0.007100:0.013181:0.012508:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.012604:0.011738:0.008313:0.012604:0.006042:0.008313:0.003848:0.003848:0.012950:0.011738:0.006523:0.008313:0.012450:0.011738:0.013143:0.003848:0.011738:0.007466:0.008313:0.003848:0.011738:0.008313:0.006523:0.011738:0.012508:0.008313:0.006523:0.011699:0.013123:0.011699:0.003848:0.012508:0.007466:0.005330:0.005330
causing tubular damage); hypercalcemia :@0.524251:0.277350:0.920492:0.277350:0.920492:0.261594:0.524251:0.261594:0.012450:0.013143:0.011699:0.007466:0.003848:0.011738:0.012950:0.004541:0.006523:0.011699:0.013123:0.011699:0.003848:0.013143:0.005792:0.004528:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.007100:0.005330:0.004541:0.011738:0.010314:0.013123:0.012508:0.005653:0.012450:0.013143:0.003848:0.012450:0.012508:0.018049:0.003848:0.013143:0.005330
(causing polyuria with subsequent volume :@0.524251:0.293820:0.920487:0.293820:0.920487:0.278064:0.524251:0.278064:0.007100:0.012450:0.013143:0.011699:0.007466:0.003848:0.011738:0.012950:0.005215:0.013123:0.012604:0.003848:0.010314:0.011699:0.005792:0.003848:0.013143:0.005203:0.015990:0.003848:0.006523:0.011738:0.005203:0.007466:0.011699:0.013123:0.007466:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.005195:0.010660:0.012604:0.003848:0.011699:0.018049:0.012508:0.005330
depletion which increases toxicity of the :@0.524251:0.310291:0.920508:0.310291:0.920508:0.294535:0.524251:0.294535:0.013181:0.012508:0.013123:0.003848:0.012508:0.006523:0.003848:0.012604:0.011738:0.008736:0.015990:0.011738:0.003848:0.012450:0.011738:0.008736:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.007466:0.008736:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.008736:0.012604:0.006042:0.008736:0.006523:0.011738:0.012508:0.005330
filtered light chains) and drugs (especially :@0.524251:0.326761:0.920469:0.326761:0.920469:0.311005:0.524251:0.311005:0.004686:0.004686:0.003848:0.006523:0.012508:0.005709:0.012508:0.013181:0.006308:0.003848:0.003848:0.012950:0.011738:0.006523:0.006308:0.012450:0.011738:0.013143:0.003848:0.011738:0.007466:0.007100:0.006313:0.013143:0.011738:0.013181:0.006310:0.013181:0.005792:0.011699:0.012950:0.007466:0.006304:0.007100:0.012508:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.010314:0.005330
NSAIDs, intravenous radiocontrast, antimy-:@0.524251:0.343231:0.915158:0.343231:0.915158:0.327475:0.524251:0.327475:0.014239:0.009583:0.014239:0.004349:0.014316:0.007466:0.005330:0.004512:0.003848:0.011738:0.006523:0.005792:0.013143:0.010660:0.012508:0.011738:0.012604:0.011699:0.007466:0.004512:0.005792:0.013143:0.013181:0.003848:0.012604:0.012450:0.012604:0.011738:0.006512:0.005792:0.013143:0.007466:0.006523:0.005330:0.004512:0.013143:0.011738:0.006523:0.003848:0.018049:0.010314:0.006388
eloma agents and bisphosphonates). Less :@0.524251:0.359701:0.920490:0.359701:0.920490:0.343946:0.524251:0.343946:0.012508:0.003848:0.012604:0.018049:0.013143:0.005349:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005349:0.013143:0.011738:0.013181:0.005349:0.013123:0.003848:0.007466:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.012604:0.011738:0.013143:0.006523:0.012508:0.007466:0.007100:0.005330:0.005349:0.008890:0.012508:0.007466:0.007466:0.005330
commonly, light-chain amyloidosis  (AL) :@0.524251:0.376172:0.920487:0.376172:0.920487:0.360416:0.524251:0.360416:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.003848:0.010314:0.005330:0.014663:0.003848:0.003848:0.012950:0.011738:0.006523:0.006388:0.012450:0.011738:0.013143:0.003848:0.011738:0.014663:0.013143:0.018049:0.010314:0.003848:0.012604:0.003848:0.013181:0.012604:0.007466:0.003848:0.007466:0.005330:0.009348:0.007100:0.014239:0.008890:0.007100:0.005330
and light-chain deposition disease (LCD) :@0.524251:0.392642:0.920490:0.392642:0.920490:0.376886:0.524251:0.376886:0.013143:0.011738:0.013181:0.008505:0.003848:0.003848:0.012950:0.011738:0.006523:0.006388:0.012450:0.011738:0.013143:0.003848:0.011738:0.008505:0.013181:0.012508:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.012604:0.011738:0.008505:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.008505:0.007100:0.008890:0.015644:0.014316:0.007100:0.005330
result  in  deposition  of  light  chains at  the :@0.524251:0.409112:0.920500:0.409112:0.920500:0.393356:0.524251:0.393356:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.005330:0.003492:0.003848:0.011738:0.005330:0.003492:0.013181:0.012508:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.012604:0.011738:0.005330:0.003491:0.012604:0.006042:0.005330:0.003489:0.003848:0.003848:0.012950:0.011738:0.006523:0.005330:0.003491:0.012450:0.011738:0.013143:0.003848:0.011738:0.007466:0.008832:0.013143:0.006523:0.005330:0.003492:0.006523:0.011738:0.012508:0.005330
glomerular  basement  membrane,  which :@0.524251:0.425583:0.920483:0.425583:0.920483:0.409827:0.524251:0.409827:0.012950:0.003848:0.012604:0.018049:0.012508:0.005792:0.011699:0.003848:0.013143:0.005792:0.005330:0.004539:0.013123:0.013143:0.007466:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.004539:0.018049:0.012508:0.018049:0.013123:0.005792:0.013143:0.011738:0.012508:0.005330:0.005330:0.004537:0.015990:0.011738:0.003848:0.012450:0.011738:0.005330
results in nephrotic syndrome.:@0.524251:0.442053:0.798191:0.442053:0.798191:0.426297:0.524251:0.426297:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.005330:0.003848:0.011738:0.005330:0.011738:0.012508:0.013123:0.011738:0.005707:0.012604:0.006523:0.003848:0.012450:0.005330:0.007466:0.010314:0.011738:0.013181:0.005711:0.012604:0.018049:0.012508:0.005330
Hypercalcaemia is present at diagnosis :@0.542435:0.458523:0.920483:0.458523:0.920483:0.442767:0.542435:0.442767:0.013143:0.010314:0.013123:0.012508:0.005661:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.007212:0.003848:0.007466:0.007131:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.007120:0.013143:0.006523:0.007120:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330
 :@0.699780:0.458523:0.705168:0.458523:0.705168:0.442490:0.699780:0.442490:0.005388
in 28% of patients and in a smaller propor-:@0.524251:0.474994:0.915160:0.474994:0.915160:0.459238:0.524251:0.459238:0.003848:0.011738:0.005600:0.010660:0.010660:0.014913:0.005600:0.012604:0.006042:0.005600:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005600:0.013143:0.011738:0.013181:0.005600:0.003848:0.011738:0.005600:0.013143:0.005600:0.007466:0.018049:0.013143:0.003848:0.003848:0.012508:0.005792:0.005600:0.013123:0.005715:0.012604:0.013123:0.012604:0.005773:0.006388
tion can be dangerously elevated, requir-:@0.524251:0.491464:0.915168:0.491464:0.915168:0.475708:0.524251:0.475708:0.006523:0.003848:0.012604:0.011738:0.005753:0.012450:0.013143:0.011738:0.005759:0.013123:0.012508:0.005761:0.013181:0.013143:0.011738:0.012950:0.012508:0.005705:0.012604:0.011699:0.007466:0.003848:0.010314:0.005773:0.012508:0.003848:0.012508:0.010660:0.013143:0.006523:0.012508:0.013181:0.005330:0.005759:0.005713:0.012508:0.013123:0.011699:0.003848:0.005792:0.006388
ing immediate management. Symptoms :@0.524251:0.507934:0.920479:0.507934:0.920479:0.492178:0.524251:0.492178:0.003848:0.011738:0.012950:0.009775:0.003848:0.018049:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.009775:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006512:0.005330:0.009775:0.009583:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330
of hypercalcaemia include anorexia, :@0.524251:0.524405:0.920483:0.524405:0.920483:0.508649:0.524251:0.508649:0.012604:0.006042:0.019935:0.011738:0.010314:0.013123:0.012508:0.005657:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.019935:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.019935:0.013143:0.011738:0.012604:0.005707:0.012508:0.009236:0.003848:0.013143:0.005330:0.005330
nausea, vomiting,  polyuria, polydipsia, :@0.524251:0.540875:0.920479:0.540875:0.920479:0.525119:0.524251:0.525119:0.011738:0.013143:0.011699:0.007466:0.012508:0.013143:0.005330:0.016933:0.010660:0.012604:0.018049:0.003848:0.006523:0.003848:0.011738:0.012950:0.005330:0.005330:0.011592:0.013123:0.012604:0.003848:0.010314:0.011699:0.005792:0.003848:0.013143:0.005330:0.016933:0.013123:0.012604:0.003848:0.010314:0.013181:0.003848:0.013123:0.007466:0.003848:0.013143:0.005330:0.005330
weakness, confusion, or a decreased level :@0.524251:0.557345:0.920496:0.557345:0.920496:0.541589:0.524251:0.541589:0.015990:0.012508:0.013143:0.009660:0.011738:0.012508:0.007466:0.007466:0.005330:0.004407:0.012450:0.012604:0.011738:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.005330:0.004407:0.012604:0.005792:0.004397:0.013143:0.004407:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.013181:0.004407:0.003848:0.012508:0.010660:0.012508:0.003848:0.005330
of consciousness.:@0.524251:0.573816:0.685060:0.573816:0.685060:0.558060:0.524251:0.558060:0.012604:0.006042:0.005330:0.012450:0.012604:0.011738:0.007466:0.012450:0.003848:0.012604:0.011699:0.007466:0.011738:0.012508:0.007466:0.007466:0.005330
Patients  with  myeloma  are  at  an  in-:@0.542435:0.590286:0.915160:0.590286:0.915160:0.574530:0.542435:0.574530:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.007181:0.015990:0.003848:0.006523:0.011738:0.005330:0.007183:0.018049:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.005330:0.007187:0.013143:0.005715:0.012508:0.005330:0.007183:0.013143:0.006523:0.005330:0.007185:0.013143:0.011738:0.005330:0.007183:0.003848:0.011738:0.006388
creased risk for infection due to both im-:@0.524251:0.606756:0.915178:0.606756:0.915178:0.591000:0.524251:0.591000:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.013181:0.007524:0.005792:0.003848:0.007466:0.009660:0.007524:0.006042:0.012604:0.005792:0.007524:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.007524:0.013181:0.011699:0.012508:0.007524:0.006523:0.012604:0.007524:0.013123:0.012604:0.006523:0.011738:0.007524:0.003848:0.018049:0.006388
mune  dysfunction and functional factors :@0.524251:0.623226:0.920517:0.623226:0.920517:0.607471:0.524251:0.607471:0.018049:0.011699:0.011738:0.012508:0.005330:0.003067:0.013181:0.010314:0.007466:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.008409:0.013143:0.011738:0.013181:0.008409:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.008409:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.005330
and an infection may be the presenting :@0.524251:0.639697:0.920529:0.639697:0.920529:0.623941:0.524251:0.623941:0.013143:0.011738:0.013181:0.008447:0.013143:0.011738:0.008447:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.008447:0.018049:0.013143:0.010314:0.008447:0.013123:0.012508:0.008447:0.006523:0.011738:0.012508:0.008447:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.003848:0.011738:0.012950:0.005330
symptom. Immune dysfunction may result :@0.524251:0.656167:0.920488:0.656167:0.920488:0.640411:0.524251:0.640411:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.005330:0.006548:0.004349:0.018049:0.018049:0.011699:0.011738:0.012508:0.006542:0.013181:0.010314:0.007466:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.006546:0.018049:0.013143:0.010314:0.006552:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.005330
from a decrease in normal immunoglob-:@0.524251:0.672637:0.915160:0.672637:0.915160:0.656881:0.524251:0.656881:0.006042:0.005711:0.012604:0.018049:0.007936:0.013143:0.007947:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.007947:0.003848:0.011738:0.007947:0.011738:0.012604:0.006315:0.018049:0.013143:0.003848:0.007947:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.012950:0.003848:0.012604:0.013100:0.006388
ins (hypogammaglobulinaemia) and im-:@0.524251:0.689108:0.915160:0.689108:0.915160:0.673352:0.524251:0.673352:0.003848:0.011738:0.007466:0.009948:0.007100:0.011738:0.010314:0.013123:0.012604:0.012950:0.013143:0.018049:0.018049:0.013143:0.012950:0.003848:0.012604:0.013123:0.011699:0.003848:0.003848:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.007100:0.009948:0.013143:0.011738:0.013181:0.009948:0.003848:0.018049:0.006388
paired function  or  number  of  neutrophils :@0.524251:0.705578:0.920488:0.705578:0.920488:0.689822:0.524251:0.689822:0.013123:0.013143:0.003848:0.005721:0.012508:0.013181:0.008409:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.003061:0.012604:0.005792:0.005330:0.003065:0.011738:0.011699:0.018049:0.013123:0.012508:0.005792:0.005330:0.003065:0.012604:0.006042:0.005330:0.003069:0.011738:0.012508:0.011699:0.006523:0.005703:0.012604:0.013123:0.011738:0.003848:0.003848:0.007466:0.005330
and lymphocytes.:@0.524251:0.722048:0.691910:0.722048:0.691910:0.706292:0.524251:0.706292:0.013143:0.011738:0.013181:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.012450:0.010314:0.006523:0.012508:0.007466:0.005330
Neurological  disease can  result  from :@0.542435:0.738519:0.920504:0.738519:0.920504:0.722763:0.542435:0.722763:0.014047:0.012315:0.011507:0.005521:0.012411:0.003656:0.012411:0.012758:0.003656:0.012257:0.012950:0.003656:0.005330:0.010035:0.012989:0.003656:0.007274:0.012315:0.012950:0.007274:0.012508:0.015348:0.012257:0.012950:0.011545:0.005330:0.010035:0.005521:0.012315:0.007274:0.011507:0.003656:0.006331:0.005330:0.010035:0.005850:0.005519:0.012411:0.018049:0.005330
 :@0.743718:0.738519:0.749106:0.738519:0.749106:0.722485:0.743718:0.722485:0.005388
nerve or spinal cord compression, either :@0.524270:0.754989:0.920558:0.754989:0.920558:0.739233:0.524270:0.739233:0.011545:0.012315:0.005600:0.010468:0.012315:0.010603:0.012411:0.005600:0.010603:0.007274:0.012931:0.003656:0.011545:0.012950:0.003656:0.010603:0.012257:0.012411:0.005482:0.012989:0.010603:0.012257:0.012411:0.017857:0.012931:0.005519:0.012315:0.007274:0.007274:0.003656:0.012411:0.011545:0.005138:0.010603:0.012315:0.003656:0.006331:0.011545:0.012315:0.005788:0.005330
from a collapsed vertebra or an extramed-:@0.524270:0.771459:0.915195:0.771459:0.915195:0.755703:0.524270:0.755703:0.005850:0.005519:0.012411:0.017857:0.004849:0.012950:0.004849:0.012257:0.012411:0.003656:0.003656:0.012950:0.012931:0.007274:0.012315:0.012989:0.004849:0.010468:0.012315:0.005600:0.006331:0.012315:0.012931:0.005600:0.012950:0.004849:0.012411:0.005600:0.004849:0.012950:0.011545:0.004849:0.012315:0.009044:0.006331:0.005600:0.012950:0.017857:0.012315:0.012989:0.006388
ullary plasmacytoma. Spinal cord com-:@0.524270:0.787930:0.915179:0.787930:0.915179:0.772174:0.524270:0.772174:0.011507:0.003656:0.003656:0.012950:0.005600:0.010122:0.012989:0.012931:0.003656:0.012950:0.007274:0.017857:0.012950:0.012257:0.010122:0.006331:0.012411:0.017857:0.012950:0.005138:0.012989:0.009390:0.012931:0.003656:0.011545:0.012950:0.003656:0.012989:0.012257:0.012411:0.005482:0.012989:0.012989:0.012448:0.012600:0.018076:0.006388
pression should be suspected in patients :@0.524270:0.804400:0.920529:0.804400:0.920529:0.788644:0.524270:0.788644:0.013123:0.005715:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.008582:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.008582:0.013123:0.012508:0.008582:0.007466:0.011699:0.007466:0.013123:0.012508:0.012450:0.006523:0.012508:0.013181:0.008582:0.003848:0.011738:0.008582:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
presenting  with  severe  back  pain along :@0.524270:0.820870:0.920515:0.820870:0.920515:0.805114:0.524270:0.805114:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.003848:0.011738:0.012950:0.005330:0.004428:0.015990:0.003848:0.006523:0.011738:0.005330:0.004435:0.007466:0.012508:0.010660:0.012508:0.005715:0.012508:0.005330:0.004432:0.013123:0.013143:0.012450:0.009660:0.005330:0.004433:0.013123:0.013143:0.003848:0.011738:0.009775:0.013143:0.003848:0.012604:0.011738:0.012950:0.005330
with  weakness  or  paraesthesia of  the :@0.524270:0.837340:0.920515:0.837340:0.920515:0.821585:0.524270:0.821585:0.015990:0.003848:0.006523:0.011738:0.005330:0.009496:0.015990:0.012508:0.013143:0.009660:0.011738:0.012508:0.007466:0.007466:0.005330:0.009496:0.012604:0.005792:0.005330:0.009488:0.013123:0.013143:0.005792:0.013143:0.012508:0.007466:0.006523:0.011738:0.012508:0.007466:0.003848:0.013143:0.014836:0.012604:0.006042:0.005330:0.009490:0.006523:0.011738:0.012508:0.005330
lower  limbs, and bladder or bowel dys-:@0.524270:0.853811:0.915195:0.853811:0.915195:0.838055:0.524270:0.838055:0.003848:0.012604:0.015990:0.012508:0.005792:0.005330:0.004970:0.003848:0.003848:0.018049:0.013123:0.007466:0.005330:0.010314:0.013143:0.011738:0.013181:0.010314:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.010314:0.012604:0.005782:0.010314:0.013123:0.012604:0.015990:0.012508:0.003848:0.010314:0.013181:0.010314:0.007466:0.006388
function. This is a :@0.524270:0.870281:0.681929:0.870281:0.681929:0.854525:0.524270:0.854525:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.004874:0.008197:0.011738:0.003848:0.007466:0.004888:0.003848:0.007466:0.004888:0.013143:0.005330
medical emergency:@0.681486:0.870281:0.872217:0.870281:0.872217:0.854525:0.681486:0.854525:0.018049:0.012508:0.013181:0.003848:0.012450:0.013143:0.003848:0.004888:0.012508:0.018049:0.012508:0.005792:0.012950:0.012508:0.011738:0.012450:0.010314
 and :@0.872230:0.870281:0.920510:0.870281:0.920510:0.854525:0.872230:0.854525:0.004888:0.013143:0.011738:0.013181:0.005330
the patient should be urgently referred for :@0.524270:0.886751:0.920510:0.886751:0.920510:0.870995:0.524270:0.870995:0.006523:0.011738:0.012508:0.005465:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.005465:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005465:0.013123:0.012508:0.005465:0.011699:0.005805:0.012950:0.012508:0.011738:0.006523:0.003848:0.010314:0.005465:0.005711:0.012508:0.006042:0.012508:0.005792:0.005705:0.012508:0.013181:0.005465:0.006042:0.012604:0.005792:0.005330
imaging (MRI preferred over CT), with an :@0.524270:0.903222:0.920529:0.903222:0.920529:0.887466:0.524270:0.887466:0.003848:0.018049:0.013143:0.012950:0.003848:0.011738:0.012950:0.007620:0.007100:0.017684:0.011680:0.004349:0.007620:0.013123:0.005713:0.012508:0.006042:0.012508:0.005792:0.005703:0.012508:0.013181:0.007620:0.012604:0.010660:0.012508:0.005792:0.007607:0.015644:0.008197:0.007100:0.005330:0.007608:0.015990:0.003848:0.006523:0.011738:0.007620:0.013143:0.011738:0.005330
urgent assessment by a haematologist or :@0.524270:0.919692:0.920529:0.919692:0.920529:0.903936:0.524270:0.903936:0.011699:0.005805:0.012950:0.012508:0.011738:0.006523:0.007077:0.013143:0.007466:0.007466:0.012508:0.007466:0.007466:0.018049:0.012508:0.011738:0.006523:0.007100:0.013123:0.010314:0.007100:0.013143:0.007091:0.011738:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.007081:0.012604:0.005792:0.005330
oncologist  and  neurosurgeon.  Peripheral :@0.524270:0.936162:0.920513:0.936162:0.920513:0.920406:0.524270:0.920406:0.012604:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.005330:0.004058:0.013143:0.011738:0.013181:0.005330:0.004068:0.011738:0.012508:0.011699:0.005705:0.012604:0.007466:0.011699:0.005805:0.012950:0.012508:0.012604:0.011726:0.005330:0.005330:0.004066:0.011392:0.012508:0.005792:0.003848:0.013123:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330